Changes of thick filament structure during contraction of frog striated muscle

Biophysical Journal
N YagiI Matsubara

Abstract

The strongest myosin-related features in the low-angle axial x-ray diffraction pattern of resting frog sartorius muscle are the meridional reflections corresponding to axial spacings of 21.4 and 14.3 nm, and the first layer line, at a spacing 42.9 nm. During tetanus the intensities of the first layer line and the 21.4-nm meridional decrease by 62 and 80% respectively, but, when the muscle is fresh, the 14.3-nm meridional intensity rises by 13%, although it shows a decrease when the muscle is fatigued. The large change in the intensity of the 21.4-nm meridional reflection suggests that the projected myosin cross-bridge density onto the thick filament axis changes during contraction. The model proposed by Bennett (Ph.D. Thesis, University of London, 1977) in which successive cross-bridge levels are at 0,3/8, and 5/8 of the 42.9-nm axial repeat in the resting muscle, passing to 0, 1/3, and 2/3 in the contracting state, can explain why the 21.4-nm reflection decreases in intensity while the 14.3-nm increases when the muscle is activated. The model predicts a rather larger increase of the 14.3-nm reflection intensity during contraction than that observed, but the discrepancy may be removed if a small change of shape or tilt of the c...Continue Reading

Citations

Apr 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·T Matsuda, R J Podolsky
Jun 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·M LinariV Lombardi
Feb 1, 1986·The Journal of Cell Biology·M Cantino, J Squire
Jun 1, 1983·The Journal of Cell Biology·R W Kensler, M Stewart
Feb 22, 2012·Biochemistry. Biokhimii︠a︡·N A Koubassova, A K Tsaturyan
Apr 24, 2008·Cell Motility and the Cytoskeleton·Hiroyuki Iwamoto
Oct 10, 2006·Biophysical Journal·Naoto Yagi
Feb 22, 2005·Journal of Structural Biology·Robert W Kensler
Jul 22, 2015·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Takeyuki Wakabayashi
Oct 1, 2006·Reports on Progress in Physics·Massimo Reconditi
Jan 1, 1987·Annals of the New York Academy of Sciences·K W MillerS A Forman
Dec 1, 1982·Pflügers Archiv : European journal of physiology·F SachsN Barkakati
Apr 1, 1992·Journal of Muscle Research and Cell Motility·N YagiY Amemiya
Feb 1, 1995·Journal of Muscle Research and Cell Motility·R W Kensler, J L Woodhead
Aug 1, 1993·Journal of Muscle Research and Cell Motility·K Hirose, T Wakabayashi
Aug 1, 1992·Journal of Muscle Research and Cell Motility·S B Malinchik, V V Lednev
Dec 11, 1989·Biochimica Et Biophysica Acta·S A FormanK W Miller
Dec 20, 1986·Journal of Molecular Biology·M Stewart, R W Kensler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.